Skip to main content

Advertisement

Table 1 Assessment schedule

From: Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study

Week BL Tx W24 W25 W26 W27 W28 W30 W34 W38 W42 W46 W52
Informed consent X             
Medical history X X            
Transplantation information   X            
Concomitant medication X X X X X X X X X X X X X
Physical examination X X X X X X X X X X X X X
Routine lab X X X X X X X X X X X X X
Urinalysis X X X X X X X X X X X X X
CMV, EBV and BK viral load    X X   X   X   X   X X
MSC infusion     X X         
Renal biopsy   X X           X
Iohexol clearance    X           X
Immune monitoring   X X Xa Xa X    X     X
DSA X X X      X      X
Safety assesment X X X X X X X X X X X X X
  1. BL baseline, Tx renal transplantation
  2. abefore and 4 h after MSC infusion